NCT04709458 2022-05-03Safety and Early Efficacy Study of TBX-2400 in Patients With AML or MyelofibrosisTaiga Biotechnologies, Inc.Phase 1 Unknown10 enrolled
NCT01286077 2016-05-30Velcade Consolidation Bone StudyJanssen-Cilag International NVPhase 2 Completed106 enrolled 19 charts
NCT00431340 2015-07-08A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple MyelomaValerio TherapeuticsPhase 2 Terminated4 enrolled
NCT00908232 2015-01-15SEQUENTIALJanssen-Cilag International NVPhase 2 Completed163 enrolled 11 charts
NCT00113893 2013-11-07SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.Scios, Inc.Phase 2 Completed62 enrolled
NCT00421213 2012-07-19Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow CancersAlaunos TherapeuticsPhase 2 Completed50 enrolled